STACY RESCHKE: Open Payments
NPI 1467896886 · MARION, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 30 payments from 11 companies in 2025. Trend: 2023 $342 · 2024 $634 · 2025 $810
Food & beverage: $616Education: $194
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $268 |
| Lilly USA, LLC | 4 | $110 |
| Janssen Biotech, Inc. | 5 | $89 |
| E.R. Squibb & Sons, L.L.C. | 4 | $69 |
| Merck Sharp & Dohme LLC | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
| Caris MPI, Inc. | 2 | $52 |
| BeiGene USA, Inc. | 1 | $26 |
| KYOWA KIRIN, INC. | 1 | $24 |
| PharmaEssentia USA Corporation | 1 | $22 |
Products named: VERZENIO, Vyloy, OPDIVO, TECVAYLI, MI CANCER SEEK, KEYTRUDA, ICLUSIG, BRUKINSA.
Industry payments across AR — which companies pay providers there.
